Table 1

Preliminary observation, informants and interviews

Preliminary observation
ActivitiesYear
Two factory visits at multinational pharmaceutical companies2019
Two events on pharmaceutical strategic marketing and MA2018, 2019
Three thematic workshops on MA2019
Informal conversations with experts in the field2018, 2019
Data collection through in-depth interviews
RespondentsPositionNo. of interviewsYear
R1Health, Economics and Outcomes Research Specialist22019
R2Marketing & Communication Consultant for pharmaceutical companies32019, 2020
R3Pharmaceutical Consultant32019
R4Regional Commercial Director42019, 2020
R5Corporate Affairs Director52019, 2020
R6Regulatory & Price Reimbursement Access Director42019, 2020
R7Member of a Patient Association12019
R8Strategic & Trade Marketing Consultant32019
R9Regulatory Affairs Sr Manager12020
R10Former Deputy and Council Member12020
R11Market Access, Government Affairs & Business Intelligence Sr Director32019
R12Hospital Pharmacy Director12020
R13Market Access Manager22019, 2020
R14Institutional Affairs Head12019
R15External Relations, Market Access and Regulatory Director12019
R16Health Economic and Market Access Consultant, Member of AGENAS12019

or Create an Account

Close Modal
Close Modal